Skip to main content
Addgene

TNO155 is a selective SHP2 inhibitor to target PTPN11-dependent oral squamous cell carcinoma.

Chai AWY, Tan YH, Ooi S, Yee PS, Yee SM, Cheong SC
Heliyon. 2024 Oct 22;10(21):e39677. doi: 10.1016/j.heliyon.2024.e39677. eCollection 2024 Nov 15. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

ID Plasmid Purpose
208427pKLV2-U6gRNA5(hPTPN11_1k)-PGKpuro2ABFP-WLentiviral gRNA plasmid targeting human PTPN11 gene, co-expression of BFP tag
208428pKLV2-U6gRNA5(hPTPN11_2b)-PGKpuro2ABFP-WLentiviral gRNA plasmid targeting human PTPN11 gene, co-expression of BFP tag
208429pKLV2-U6gRNA5(hMTOR_1k)-PGKpuro2ABFP-WLentiviral gRNA plasmid targeting human MTOR gene, co-expression of BFP tag
208430pKLV2-U6gRNA5(hMTOR_2b)-PGKpuro2ABFP-WLentiviral gRNA plasmid targeting human MTOR gene, co-expression of BFP tag
208431pKLV2-U6gRNA5(hEGFR_1k)-PGKpuro2ABFP-WLentiviral gRNA plasmid targeting human EGFR gene, co-expression of BFP tag
208432pKLV2-U6gRNA5(hEGFR_2b)-PGKpuro2ABFP-WLentiviral gRNA plasmid targeting human EGFR gene, co-expression of BFP tag

Antibodies from Article